Skip to main content

Antivenin (crotalidae) polyvalent Pregnancy and Breastfeeding Warnings

Medically reviewed by Last updated on Jul 4, 2022.

Antivenin (crotalidae) polyvalent is also known as: Anavip, Antivenin Polyvalent, CroFab

Antivenin (crotalidae) polyvalent Pregnancy Warnings

Animal studies have not been conducted. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Use is not recommended unless clearly needed.

US FDA pregnancy category: C

-This product contains ethyl mercury from thimerosal.
-Limited data on high dose and acute exposures to methyl mercury associate it with neurological and renal toxicities.
-Developing fetuses and very young children are more susceptible to methyl mercury toxicity.

See references

Antivenin (crotalidae) polyvalent Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

See references

References for pregnancy information

  1. "Product Information. CroFab (antivenin (Crotalidae) polyvalent)." Savage Laboratories

References for breastfeeding information

  1. "Product Information. CroFab (antivenin (Crotalidae) polyvalent)." Savage Laboratories

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.